Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

PSCHvsSBIOETF Comparison

ETF 1
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
+0.32%
VS
ETF 2
SBIO

ALPS Medical Breakthroughs ETF

This fund is part of
Tomorrow's Treatments
-0.65%

Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. ALPS Medical Breakthroughs ETF (SBIO) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.5% for SBIO. PSCH is up 20.24% year-to-date (YTD) with -$10M in YTD flows. SBIO performs better with 24.58% YTD performance, and +$41M in YTD flows. Run a side-by-side ETF comparison of PSCH and SBIO below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PSCH vs SBIO performance and flow charts

Performance

02468101214%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

0 M5 M10 M15 M20 MJun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
PSCH
SBIO
+5.27%+4.86%
+19.02%+17.16%
+20.24%+24.58%
+36.79%+91.81%
+19.78%+109.04%
-15.14%+48.00%
Flows
PSCH
SBIO
+$6M+$18M
+$9M+$24M
-$10M+$41M
-$13M+$51M
-$133M+$20M
-$230M-$24M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PSCH
SBIO
+17.29%+35.36%
+20.07%+30.55%
+21.86%+30.92%
+22.90%+33.95%
Max drawdown
PSCH
SBIO
-2.96%-10.73%
-15.36%-12.63%
-22.80%-42.12%
-46.32%-52.50%
Max drawdown duration
PSCH
SBIO
17d43d
168d60d
488d331d
1786d1479d
Trading data

Create an account to view trading data

Join for free
PSCH
SBIO
Last sale
7/27/2026 at 5:11 PM
$53.16
$64.68
Previous close
07/24/2026
$52.95
$63.77
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PSCH
SBIO
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 5:11 PM
Live
Closed
PSCH
SBIO
Last price
$53.16
$64.68
1D performance
+0.40%
+1.43%
AuM$162.74 M$202.25 M
E/R0.29%0.5%
Characteristics
PSCH
SBIO
Management strategyPassivePassive
ProviderInvescoALPS
BenchmarkS&P SmallCap 600 Capped Health Care IndexS-Network Medical Breakthroughs Index
N° of holdings75103
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 7, 2010December 30, 2014
ESGNoNo
Advertisement
Exposure

Countries

PSCH
USA
95.33%
Other
4.67%
SBIO
USA
88.02%
Other
11.98%

Sectors

PSCH
Healthcare
100%
Other
0%
SBIO
Healthcare
99.06%
Other
0.94%
Advertisement

Diversification

PSCH

Total weight of top 15 holdings out of 15

49.48%
SBIO

Total weight of top 15 holdings out of 15

40.08%

Top 15 holdings

Data as of June 30, 2026
PSCH
Molina Healthcare, Inc.
5.29%
BrightSpring Health Services, Inc.
4.82%
Krystal Biotech, Inc.
4.32%
Alkermes Plc
4.06%
Glaukos Corp.
3.75%
Corcept Therapeutics, Inc.
3.69%
Protagonist Therapeutics, Inc.
3.26%
TG Therapeutics, Inc.
3.25%
PTC Therapeutics, Inc.
3.10%
Ligand Pharmaceuticals, Inc.
2.69%
Teleflex, Inc.
2.54%
Liquidia Corp.
2.43%
Indivior Pharmaceuticals, Inc.
2.25%
Veracyte, Inc.
2.13%
RadNet, Inc.
1.90%
SBIO
Apogee Therapeutics, Inc.
4.36%
CG Oncology, Inc.
3.33%
Xenon Pharmaceuticals, Inc.
3.09%
Oruka Therapeutics, Inc.
3.05%
Dianthus Therapeutics, Inc.
2.83%
Travere Therapeutics, Inc.
2.80%
Definium Therapeutics, Inc.
2.73%
Veradermics, Inc.
2.72%
Edgewise Therapeutics, Inc.
2.32%
ACADIA Pharmaceuticals, Inc.
2.30%
Denali Therapeutics, Inc.
2.17%
Relay Therapeutics, Inc.
2.17%
NewAmsterdam Pharma Co. NV
2.10%
Crinetics Pharmaceuticals, Inc.
2.09%
Structure Therapeutics, Inc.
2.02%
Frequently asked questions about PSCH and SBIO

How have the PSCH and SBIO ETFs performed in 2026?

As of July 24, 2026, PSCH is up 20.24% year-to-date (YTD), while SBIO has returned 24.58%. That puts SBIO better performer ahead so far this year.

Which ETF is attracting more investor money: PSCH or SBIO?

Year-to-date, the PSCH ETF saw -$10M in flows, compared to +$41M for SBIO.

Which ETF is more volatile: PSCH or SBIO?

Over the past year, PSCH had a volatility of 20.07%, while SBIO experienced 30.55%.

Which ETF is bigger: PSCH or SBIO?

As of July 24, 2026, PSCH holds $162.74 M in assets under management (AUM), while SBIO manages $202.25 M.

What sectors do the PSCH and SBIO ETFs invest in?

PSCH leans toward sectors like Healthcare. Meanwhile, SBIO focuses on Healthcare.

What are the top holdings of the PSCH ETF and SBIO ETF?

PSCH top holdings include Molina Healthcare, Inc., BrightSpring Health Services, Inc. and Krystal Biotech, Inc.. SBIO holds in its top three: Apogee Therapeutics, Inc., CG Oncology, Inc. and Xenon Pharmaceuticals, Inc..

Which ETF is more diversified: PSCH or SBIO?

PSCH holds 75 securities with 49.48% of its assets in the top 15. SBIO has 104 securities and a top 15 weight of 40.08%.

Advertisement
Latest news about PSCH & SBIO
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder